Sumitomo Mitsui Financial Group Inc. trimmed its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 50.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 471,846 shares of the financial services provider’s stock after selling 471,846 shares during the quarter. CME Group comprises 2.2% of Sumitomo Mitsui Financial Group Inc.’s portfolio, making the stock its 8th biggest holding. Sumitomo Mitsui Financial Group Inc.’s holdings in CME Group were worth $123,614,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in CME. BlackRock Inc. bought a new position in shares of CME Group in the 2nd quarter valued at about $6,749,965,000. Bank of America Corp DE lifted its holdings in shares of CME Group by 39.1% during the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock valued at $1,187,290,000 after purchasing an additional 1,130,587 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of CME Group during the second quarter worth $867,313,000. Alphabet Inc. bought a new stake in shares of CME Group in the second quarter valued at about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of CME Group during the 2nd quarter worth approximately $629,771,000. Institutional investors own 87.75% of the company’s stock.
Insider Activity at CME Group
In other news, General Counsel John Marchese sold 655 shares of the firm’s stock in a transaction dated Wednesday, November 18th. The stock was sold at an average price of $310.75, for a total value of $203,541.25. Following the completion of the sale, the general counsel directly owned 2,943 shares in the company, valued at $914,537.25. This trade represents a 18.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Sunil Cutinho sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 27th. The shares were sold at an average price of $298.70, for a total value of $1,493,500.00. Following the completion of the sale, the insider directly owned 20,037 shares of the company’s stock, valued at $5,985,051.90. This trade represents a 19.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 61,166 shares of company stock worth $18,276,512. 0.30% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of research analysts have weighed in on CME shares. Wells Fargo & Company raised their price target on CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. Barclays boosted their price objective on shares of CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a report on Thursday, October 22nd. Piper Sandler restated an “overweight” rating and issued a $330.00 price target (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. TD Cowen boosted their price objective on shares of CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a research report on Monday, October 5th. Finally, JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 target price for the company in a report on Thursday, October 22nd. Ten investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $314.44.
Read Our Latest Stock Report on CME Group
More CME Group News
Investors following CME have been watching these news items:
- Positive Sentiment: CME reported that XRP and Micro XRP futures generated $81.2 billion in notional volume across roughly 18 months, averaging $216 million per day through mid-November. Strong activity may support transaction and clearing revenue. Article
- Positive Sentiment: CME’s latest reported quarter beat analyst expectations: earnings were $3.02 per share versus a $2.99 consensus, while revenue of $1.74 billion exceeded estimates and grew 10.6% year over year. Article
- Negative Sentiment: CEO Terrence Duffy sold 27,000 shares, reducing his direct holdings by about 43%; General Counsel John Marchese also sold 655 shares. Insider sales can be for personal reasons and do not necessarily signal weaker prospects, but may weigh on sentiment. CEO sale report General counsel sale report
CME Group Stock Performance
Shares of CME stock opened at $307.54 on Friday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The business’s 50 day simple moving average is $289.43 and its 200 day simple moving average is $282.08. The stock has a market capitalization of $110.08 billion, a PE ratio of 25.23, a PEG ratio of 3.90 and a beta of 0.15. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.03. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. CME Group’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.68 earnings per share. As a group, research analysts forecast that CME Group Inc. will post 12.36 earnings per share for the current year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group’s payout ratio is presently 42.66%.
CME Group Company Profile
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Featured Stories
- Five stocks we like better than CME Group
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
